Placemark Investments’s Edwards Lifesciences EW Stock Holding History

Placemark Investments’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$916K	Buy	43,164 +17,574	+69%	+$353K	0.02%	915
2014 Q3	$436K	Buy	25,590 +6,966	+37%	+$110K	0.01%	1223
2014 Q2	$268K	Sell	18,624 -28,566	-61%	-$387K	﹤0.01%	1439
2014 Q1	$583K	Sell	47,190 -9,534	-17%	-$110K	0.01%	1055
2013 Q4	$622K	Buy	56,724 +10,068	+22%	+$113K	0.01%	1050
2013 Q3	$542K	Buy	46,656 +10,758	+30%	+$126K	0.01%	1052
2013 Q2	$402K	Buy	+35,898	New	+$425K	0.01%	1133

Other funds holding EW

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Placemark Investments's EW Position: Q4 2014 in Review

Placemark Investments increased its Edwards Lifesciences (EW) stake by 69% in Q4 2014, buying an estimated $353K and bringing the position to 43,164 shares worth $916K. The position accounts for 0.02% of the portfolio, ranked #915.

Placemark Investments first reported a position in EW in Q2 2013 and has held it in 7 quarters since. 556 funds tracked by Wall St. Rank hold EW as of Q4 2014.

Placemark Investments held 43,164 shares of Edwards Lifesciences worth $916K as of Q4 2014.
Placemark Investments bought 17,574 Edwards Lifesciences shares in Q4 2014, an estimated $353K.
Edwards Lifesciences made up 0.02% of Placemark Investments's portfolio in Q4 2014, its #915 holding.
Placemark Investments first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 7 quarters since.
556 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.